Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2000 6
2001 5
2002 4
2003 8
2004 5
2005 9
2006 3
2007 4
2008 6
2009 7
2010 8
2011 7
2012 7
2013 4
2014 6
2015 5
2016 4
2017 5
2018 6
2019 8
2020 11
2021 14
2022 8
2023 9
2024 9
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJM, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A, Janikova A, Cwynarski K, Mikhaeel G, Jerkeman M, Di Rocco A, Stepanishyna Y, Vitolo U, Santoro A, Re A, Puccini B, Olivieri J, Petrucci L, Barrington SF, Malkowski B, Metser U, Versari A, Chauvie S, Walewski J, Trneny M, Cavalli F, Gospodarowicz M, Johnson PWM, Davies A, Zucca E; International Extranodal Lymphoma Study Group (IELSG). Martelli M, et al. J Clin Oncol. 2024 Dec;42(34):4071-4083. doi: 10.1200/JCO-24-01373. Epub 2024 Aug 19. J Clin Oncol. 2024. PMID: 39159403 Clinical Trial.
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).
Bachy E, Camus V, Thieblemont C, Sibon D, Casasnovas RO, Ysebaert L, Damaj G, Guidez S, Pica GM, Kim WS, Lim ST, André M, García-Sancho AM, Penarrubia MJ, Staber PB, Trotman J, Hüttmann A, Stefoni V, Re A, Gaulard P, Delfau-Larue MH, de Leval L, Meignan M, Li J, Morschhauser F, Delarue R. Bachy E, et al. Among authors: stefoni v. J Clin Oncol. 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. Epub 2021 Nov 29. J Clin Oncol. 2022. PMID: 34843406 Clinical Trial.
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
Camus V, Thieblemont C, Gaulard P, Cheminant M, Casasnovas RO, Ysebaert L, Damaj GL, Guidez S, Pica GM, Kim WS, Lim ST, Andre M, Gutiérrez N, Penarrubia MJ, Staber PB, Trotman J, Hüttmann A, Stefoni V, Tucci A, Fogarty P, Farhat H, Abraham J, Abarah W, Belmecheri F, Ribrag V, Delfau-Larue MH, Cottereau AS, Itti E, Li J, Delarue R, de Leval L, Morschhauser F, Bachy E. Camus V, et al. Among authors: stefoni v. J Clin Oncol. 2024 May 10;42(14):1612-1618. doi: 10.1200/JCO.23.01687. Epub 2024 Feb 16. J Clin Oncol. 2024. PMID: 38364196 Clinical Trial.
Clinical biology of artificial organ substitution.
Stefoni S, La Manna G, De Sanctis LB, Dalmastri V, Perna C, Pace G, Donati G, De Pascalis A, Bertuzzi V, Stefoni V, Zanchelli F. Stefoni S, et al. Among authors: stefoni v. Nephrol Dial Transplant. 1998;13 Suppl 7:51-4. doi: 10.1093/ndt/13.suppl_7.51. Nephrol Dial Transplant. 1998. PMID: 9870438 Review. No abstract available.
Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients.
Tavarozzi R, Ferrero S, Evangelista A, Genuardi E, Drandi D, Mian M, Zanni M, Cavallo F, Di Rocco A, Stefoni V, Pagani C, Re A, Botto B, Balzarotti M, Zilioli VR, da Silva MG, Arcaini L, Molinari AL, Ballerini F, Ferreri AJM, Puccini B, Visco C, Stefani PM, Luppi M, Casaroli I, Stelitano C, Ciccone G, Vitolo U, Martelli M, Cortelazzo S, Ladetto M. Tavarozzi R, et al. Among authors: stefoni v. Hemasphere. 2025 Mar 22;9(3):e70102. doi: 10.1002/hem3.70102. eCollection 2025 Mar. Hemasphere. 2025. PMID: 40124719 Free PMC article. No abstract available.
Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma.
Mazzoni C, Argnani L, Casadei B, Broccoli A, Gabrielli G, Fabbri N, Gugliotta G, Pellegrini C, Carella M, Bagnato G, Gentilini M, Morigi A, Maglio P, Cantelli M, Stefoni V, Zinzani PL. Mazzoni C, et al. Among authors: stefoni v. Eur J Haematol. 2025 Jan;114(1):70-78. doi: 10.1111/ejh.14306. Epub 2024 Sep 18. Eur J Haematol. 2025. PMID: 39295142 Free PMC article.
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.
Ragaini S, Galli A, Genuardi E, Gandossini M, Alessandria B, Civita AM, Evangelista A, Amaducci E, Stefoni V, Cavallo F, Ballerini F, Puccini B, Vallisa D, Michieli M, Pascarella A, Palmas A, Patti C, Lucchini E, Careddu MG, Merli M, Postorino M, Boccomini C, Balzarotti M, Zilioli VR, Gomes da Silva M, Bruno B, Rizzo E, Ladetto M, Malcovati L, Ferrero S. Ragaini S, et al. Among authors: stefoni v. Blood Adv. 2025 Apr 22;9(8):1805-1815. doi: 10.1182/bloodadvances.2024014948. Blood Adv. 2025. PMID: 39808795 Free PMC article. Clinical Trial.
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice.
Pellegrini C, Casadei B, Broccoli A, Cantelli M, Gugliotta G, Gentilini M, Carella M, Stefoni V, Fabbri N, Gabrielli G, Argnani L, Mazzoni C, Maglio P, Bagnato G, Zinzani PL. Pellegrini C, et al. Among authors: stefoni v. Ann Hematol. 2025 Mar;104(3):1757-1764. doi: 10.1007/s00277-025-06255-8. Epub 2025 Mar 1. Ann Hematol. 2025. PMID: 40025210 Free PMC article.
154 results